Period Ending | Jun 30, 2011 | Mar 31, 2011 | Dec 31, 2010 | Sep 30, 2010 |
---|
Total Revenue
|
1,229,024
|
1,214,357
|
1,525,109
|
1,601,203
| Cost of Revenue | 371,155 | 377,462 | 557,687 | 680,754 | |
Gross Profit
|
857,869
|
836,895
|
967,422
|
920,449
| |
|
Operating Expenses |
|
Research Development | 246,513 | 243,067 | 277,822 | 269,725 |
|
Selling General and Administrative | 411,642 | 385,458 | 424,263 | 447,793 |
|
Non Recurring | 237 | 10,575 | 37,735 | 5,758 |
|
Others | 8,582 | 8,050 | 7,626 | 8,018 |
|
|
|
Total Operating Expenses | 666,974 | 647,150 | 747,446 | 731,294 | | |
Operating Income or Loss
|
190,895
|
189,745
|
219,976
|
189,155
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (5,666) | 5,027 | 7,602 | 191,351 |
|
Earnings Before Interest And Taxes | 185,229 | 194,772 | 227,578 | 380,506 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 185,229 | 194,772 | 227,578 | 380,506 |
|
Income Tax Expense | 55,629 | 52,120 | 17,142 | 86,413 |
|
Minority Interest | (1,530) | (1,840) | (5,927) | (2,128) |
|
|
|
Net Income From Continuing Ops | 236,972 | 222,992 | 312,020 | 396,131 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
236,972
|
222,992
|
312,020
|
396,131
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
236,972
|
222,992
|
312,020
|
396,131
|
|